Frederic Ginot

Frédéric Ginot is graduated from École Polytechnique (Paris – France, 1985; essentially mathematics and physics) and obtained a PhD in Molecular Biology (University Paris VII, 1989). He has more than 30 years of experience in the biology and biotechnology sector. He has managed several development teams on industrial projects, always at the interface between engineering and biosciences, especially in medical devices (Hemodia), in vitro diagnostics (BioMérieux, CEA-LETI) and molecular biology (Genethon, Bertin Technologies). Since 2014, Frederic is the CSO and CTO of Adelis SAS; his R&D team is developing the BIABooster technology, a new way of concentrating and analyzing DNA size, based on a physical phenomenon discovered in a French academic lab.

Appearances